During the past decade, Lungenfachklinik Immenhausen conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 21 clinical trials were completed, i.e. on average, 67.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 11 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lungenfachklinik Immenhausen" #1 sponsor was "Hoffmann-La Roche" with 19 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Actelion" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lungenfachklinik Immenhausen" #1 collaborator was "PneumRx, Inc." with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "Bundesverband der Pneumologen" with 1 trials as a collaborator and "CAPNETZ Stiftung" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Lungenfachklinik Immenhausen" are "Idiopathic Pulmonary Fibrosis" (13 trials), "Non-Small Cell Lung Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Emphysema" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Lungenfachklinik Immenhausen" in a lesser frequency.

Most popular intervention types in "Lungenfachklinik Immenhausen" are "Drug" (41 trials), "Device" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Atezolizumab" (8 trials), "Carboplatin" (8 trials), "Pemetrexed" (7 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Lungenfachklinik Immenhausen" are 47 trials for "All" genders.

Currently, there are NaN active trials in "Lungenfachklinik Immenhausen". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Lungenfachklinik Immenhausen, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Lungenfachklinik Immenhausen, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".